17
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Assessment of N-Nitrosodimethylamine Dna Adducts in Rat Hepatocytes by High Performance Liquid Chromatography and Immunosorbent Assay

, , , , , , & show all
Pages 165-174 | Received 28 Apr 1993, Accepted 21 Jun 1993, Published online: 04 Oct 2006
 

Abstract

A rapid and efficient enzyme-linked immunosorbent assay (ELISA) for quantification of DNA adducts was developed using affinity-purified, polyclonal antibodies directed against O6-methylguanosine (O6-meGuo) coupled to bovine serum albumin (BSA). The specificity of the antibodies was characterized by competitive inhibition assay using a number of nucleosides, nucleobases and their analogues. The O6-methylguanine (O6-meG) adduct was quantified in rat hepatocytes pretreated in vitro with N-nitrosodimethylamine (NDMA) by high performance liquid chromatography (HPLC) and compared to the data obtained by ELISA, using amplification by the avidin-biotin (AB) system. The low, 5 mM NDMA, dose induced a low cell cytotoxicity and the highest formation of the O6-meG-DNA adduct. Thus, an inverse dose-response correlation was obtained by both methods for the cell viability determined as a function of NDMA concentration and subsequent formation of the O6-meG-DNA adducts, reflecting possibly the involvement of active cell metabolism in enzymatic activation of NDMA. Quantitation of the adduct formation vs concentration of NDMA used for the incubation of cells, expressed in pg O6-meG/μg DNA, showed a good correlation (r=0.992) for both analytical methods.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.